J&J unit gets supplemental FDA OK for hip replacement device

04/29/2013 | MassDevice.com (Boston)

DePuy Orthopaedics, a unit of Johnson & Johnson, has received supplemental premarket approval from the FDA for a 36-millimeter version of its Ceramax Ceramic Total Hip System. The implantable device was first approved in 2010 for noncemented use in adult patients receiving total hip replacements.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA